Brooklyn Immunotherapeuti Stock Target Price and Analyst Consensus

BTX -  USA Stock  

USD 0.57  0.03  5.00%

The current analyst and expert consensus on Brooklyn Immunotherapeuti is Strong Buy, with 0 strong sell and 2 strong buy opinions. The current projected Brooklyn Immunotherapeuti target price consensus is 14.5 with 2 analyst opinions. The most common way Brooklyn Immunotherapeuti analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Brooklyn Immunotherapeuti executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Brooklyn Immunotherapeuti. We encourage you to use your own analysis of Brooklyn Immunotherapeuti to validate this buy or sell advice. Brooklyn Immunotherapeuti buy-or-sell recommendation module provides average expert sentiment on the projected Brooklyn Immunotherapeuti target price to derive its highest and lowest estimates based on projected price volatility of 7.778. Continue to Macroaxis Advice on Brooklyn Immunotherapeuti to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
  
Refresh
Gross Profit is likely to rise to about 12.2 M in 2022, whereas Profit Margin is likely to drop (0.13)  in 2022. Brooklyn Immunotherapeuti Investments are fairly stable at the moment as compared to the past year. Brooklyn Immunotherapeuti reported Investments of 1.15 Million in 2021. Investments Non Current is likely to rise to about 1.2 M in 2022, whereas Accounts Payable is likely to drop slightly above 2.1 M in 2022.

Brooklyn Immunotherapeuti Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Brooklyn target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Brooklyn target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Number of Opinions2
Lowered Outlook0
Raized Outlook0
Strong Buy
Most Brooklyn analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Brooklyn stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Brooklyn Immunotherapeuti, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Brooklyn Immunotherapeuti Target Price Projection

Brooklyn Immunotherapeuti's current and average target prices are 0.57 and 14.50, respectively. The current price of Brooklyn Immunotherapeuti is the price at which Brooklyn Immunotherapeutics is currently trading. On the other hand, Brooklyn Immunotherapeuti's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Brooklyn Immunotherapeuti Market Quote on 24th of June 2022

Low Price0.57Odds
High Price0.65Odds

0.57

Target Price

Analyst Consensus On Brooklyn Immunotherapeuti Target Price

Low Estimate9.0Odds
High Estimate20.0Odds
Number of Analysts2
Standard Deviation7.778

14.5

Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Brooklyn Immunotherapeutics and the information provided on this page.

Brooklyn Immunotherapeuti Analyst Ratings

Brooklyn Immunotherapeuti's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Brooklyn Immunotherapeuti stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Brooklyn Immunotherapeuti's financials, market performance, and future outlook by experienced professionals. Brooklyn Immunotherapeuti's historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

About Brooklyn Immunotherapeuti Target Price Projections

Brooklyn Immunotherapeuti's target price is an analyst's projection of its future price. Price targets can be assigned to all types of securities, from complex investment products to stocks such as Brooklyn Immunotherapeuti and even bonds. If the target price is unavailable, it is most likely because there were not enough analyst opinions to come up with a consensus estimate. When setting a price target estimate, an analyst is trying to determine what the Stock is worth and where the price will be in a year from now. Generally, the target price of Brooklyn depends on its intrinsic valuation, beta (i.e., risk over market), and overall volatility. Most analysts publish their price targets in research reports on specific companies, along with their buy, hold, or sell recommendations. Stock price targets are often quoted in the financial news media. Macroaxis uses multiple feeds to provide overall target price projection for Brooklyn Immunotherapeutics including its fundamental analysis.
 2019 2020 2021 2022 (projected)
Receivables Turnover3.6511.3510.2111.02
PPandE Turnover0.850.871.01.03

Additional Brooklyn Immunotherapeuti Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Brooklyn Immunotherapeuti is a key component of Brooklyn Immunotherapeuti valuation and have some predictive power on the future returns of a Brooklyn Immunotherapeuti.
Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Brooklyn Immunotherapeuti's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Brooklyn Immunotherapeuti in the context of predictive analytics.
Hype
Prediction
LowEstimated ValueHigh
0.570.570.57
Details
Intrinsic
Valuation
LowReal ValueHigh
0.514.054.05
Details
Naive
Forecast
LowNext ValueHigh
0.560.560.56
Details
Earnings
Estimates (1)
LowProjected EPSHigh
-2.79-2.79-2.79
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Brooklyn Immunotherapeuti. Your research has to be compared to or analyzed against Brooklyn Immunotherapeuti's peers to derive any actionable benefits. When done correctly, Brooklyn Immunotherapeuti's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy towards taking a position in Brooklyn Immunotherapeuti.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index
Invested few shares
Software
Invested over 20 shares
Continue to Macroaxis Advice on Brooklyn Immunotherapeuti to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. Note that the Brooklyn Immunotherapeuti information on this page should be used as a complementary analysis to other Brooklyn Immunotherapeuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Complementary Tools for Brooklyn Stock analysis

When running Brooklyn Immunotherapeuti price analysis, check to measure Brooklyn Immunotherapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brooklyn Immunotherapeuti is operating at the current time. Most of Brooklyn Immunotherapeuti's value examination focuses on studying past and present price action to predict the probability of Brooklyn Immunotherapeuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Brooklyn Immunotherapeuti's price. Additionally, you may evaluate how the addition of Brooklyn Immunotherapeuti to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Go
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Go
The data published in Brooklyn Immunotherapeuti's official financial statements usually reflect Brooklyn Immunotherapeuti's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Brooklyn Immunotherapeuti. For example, before you start analyzing numbers published by Brooklyn accountants, it's critical to develop an understanding of what Brooklyn Immunotherapeuti's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Brooklyn Immunotherapeuti's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Brooklyn Immunotherapeuti's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Brooklyn Immunotherapeuti's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Brooklyn Immunotherapeutics. Please utilize our Beneish M Score to check the likelihood of Brooklyn Immunotherapeuti's management to manipulate its earnings.